A Review on Method Development for the Analysis of Combine Product of Amlodipine Besilate and Rosuvastatin Calcium in Pharmaceutical Dosage form

Authors

  • Praveen Kumar Ashok Gyani Inder Singh Institute of professional Studies Dehradun
  • Saurabh Pant Gyani Inder Singh Institute of professional Studies Dehradun
  • Sonu . Gyani Inder Singh Institute of professional Studies Dehradun
  • Mandeep Limbu Gyani Inder Singh Institute of professional Studies Dehradun

DOI:

https://doi.org/10.32553/jbpr.v14i1.1224

Keywords:

Fenofibrate

Abstract

Rosuvastatin belongs to the category of statins, used in combination with calcium channel blockers, analgesicsand other class of cardiovascular disease drugs in the treatment of high cholesterol and related conditions to prevent cardiovascular diseases. The clinical and pharmaceutical analysis of these drugs requires effective analytical procedures for quality control, pharmacodynamic and pharmacokinetic studies. An extensive survey of the literature published in various analytical and pharmaceutical chemistry related journals has been conducted and the instrumentalmethods which were developed and used for determination of Rosuvastatin in combined dosage forms have been reviewed. This review covers various analytical methods for estimation of Rosuvastatin calcium and Fenofibrate in combined dosage forms, such as spectrophotometry, derivative spectrophotometry and various highperformance liquid chromatographic (HPLC) methods that were published from 2010 to 2014.

Key Words: Rosuvastatin, Fenofibrate, review, HPLC, Spectrophotometry

Downloads

Published

2025-09-17

How to Cite

Ashok, P. K. ., Pant, S. ., ., S., & Limbu, M. . (2025). A Review on Method Development for the Analysis of Combine Product of Amlodipine Besilate and Rosuvastatin Calcium in Pharmaceutical Dosage form. Journal of Biomedical and Pharmaceutical Research, 14(1), 9–16. https://doi.org/10.32553/jbpr.v14i1.1224

Issue

Vol. 14 No. 1 (2025)

Section

Articles

License

Copyright (c) 2025 Journal of Biomedical and Pharmaceutical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons LicenseJournal of Biomedical and Pharmaceutical Research by Articles is licensed under a Creative Commons Attribution 4.0 International License.